MuRF2 regulates PPAR gamma 1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet

作者：He, Jun; Quintana, Megan T.; Sullivan, Jenyth; Parry, Traci L.; Grevengoed, Trisha J.; Schisler, Jonathan C.; Hill, Joseph A.; Yates, Cecelia C.; Mapanga, Rudo F.; Essop, M. Faadiel; Stansfield, William E.; Bain, James R.; Newgard, Christopher B.; Muehlbauer, Michael J.; Han, Yipin; Clarke, Brian A.; Willis, Monte S.^*

来源：Cardiovascular Diabetology, 2015, 14(1): 97.

DOI：10.1186/s12933-015-0252-x

• MuRF2
• Diabetic cardiomyopathy
• Post-translational modification
• Multi-ubiquitin
• PPAR
• Ubiquitin ligase

Background: In diabetes mellitus the morbidity and mortality of cardiovascular disease is increased and represents an important independent mechanism by which heart disease is exacerbated. The pathogenesis of diabetic cardiomyopathy involves the enhanced activation of PPAR transcription factors, including PPAR alpha, and to a lesser degree PPAR beta and PPAR gamma 1. How these transcription factors are regulated in the heart is largely unknown. Recent studies have described post-translational ubiquitination of PPARs as ways in which PPAR activity is inhibited in cancer. However, specific mechanisms in the heart have not previously been described. Recent studies have implicated the muscle-specific ubiquitin ligase muscle ring finger-2 (MuRF2) in inhibiting the nuclear transcription factor SRF. Initial studies of MuRF2-/- hearts revealed enhanced PPAR activity, leading to the hypothesis that MuRF2 regulates PPAR activity by post-translational ubiquitination.
Methods: MuRF2-/- mice were challenged with a 26-week 60% fat diet designed to simulate obesity-mediated insulin resistance and diabetic cardiomyopathy. Mice were followed by conscious echocardiography, blood glucose, tissue triglyceride, glycogen levels, immunoblot analysis of intracellular signaling, heart and skeletal muscle morphometrics, and PPAR alpha, PPAR beta, and PPAR gamma 1-regulated mRNA expression.
Results: MuRF2 protein levels increase similar to 20% during the development of diabetic cardiomyopathy induced by high fat diet. Compared to littermate wildtype hearts, MuRF2-/- hearts exhibit an exaggerated diabetic cardiomyopathy, characterized by an early onset systolic dysfunction, larger left ventricular mass, and higher heart weight. MuRF2-/- hearts had significantly increased PPAR alpha- and PPAR gamma 1-regulated gene expression by RT-qPCR, consistent with MuRF2's regulation of these transcription factors in vivo. Mechanistically, MuRF2 mono-ubiquitinated PPAR alpha and PPAR gamma 1 in vitro, consistent with its non-degradatory role in diabetic cardiomyopathy. However, increasing MuRF2:PPAR gamma 1 (>5:1) beyond physiological levels drove poly-ubiquitin-mediated degradation of PPAR gamma 1 in vitro, indicating large MuRF2 increases may lead to PPAR degradation if found in other disease states.
Conclusions: Mutations in MuRF2 have been described to contribute to the severity of familial hypertrophic cardiomyopathy. The present study suggests that the lack of MuRF2, as found in these patients, can result in an exaggerated diabetic cardiomyopathy. These studies also identify MuRF2 as the first ubiquitin ligase to regulate cardiac PPAR alpha and PPAR gamma 1 activities in vivo via post-translational modification without degradation.

• 出版日期2015-8-5
• 单位宁夏医科大学